CREATINE KINASE ISOENZYMES (CKMB, CKBB, CKMM) - ANVISA Registration 81472060043
Access comprehensive regulatory information for CREATINE KINASE ISOENZYMES (CKMB, CKBB, CKMM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81472060043 and manufactured by manufacturer not specified. The registration is held by ADVAGEN BIOTECH LTDA with validity until May 26, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81472060043
25351454007202474
22565307000172
Company Information
Dates and Status
May 26, 2025
26/05/2035
09/18/2025 19:00:01
CREATINOQUINASE ISOENZIMAS (CKMB, CKBB, CKMM)
BIOCLIN POCT FIA CK-MB
QUIBASA QUÍMICA BÁSICA LTDA
10269360481
Sep 15, 2025
CREATINOQUINASE ISOENZIMAS (CKMB, CKBB, CKMM)
Luminis FIA CK-MB
Not specified
80474870168
Sep 08, 2025
CREATINOQUINASE ISOENZIMAS (CKMB, CKBB, CKMM)
Luminis FIA CK-MB
QINGDAO HIGHTOP BIOTECH CO.,LTD.
80474870168
Sep 08, 2025
CREATINOQUINASE ISOENZIMAS (CKMB, CKBB, CKMM)
Família Soro Controle CK-MB
BIOSYSTEMS S.A.
80367750195
Jul 28, 2025
CREATINOQUINASE ISOENZIMAS (CKMB, CKBB, CKMM)
Família Soro Controle CK-MB
Not specified
80367750195
Jul 28, 2025

